Profile data is unavailable for this security.
About the company
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
- Revenue in USD (TTM)895.48k
- Net income in USD-26.30m
- Incorporated2021
- Employees65.00
- LocationMainz Biomed NVSirius Gutenberg ParkRobert-Koch-Strasse 50MAINZ 55129GermanyDEU
- Phone+49 61 315542860
- Websitehttps://www.mainzbiomed.com/
More ▼